LBRX — LB PHARMACEUTICALS INC
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
As of Q2 2026, 121 SEC-registered investment managers reported holding LBRX (LB PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $989.67M across 30.51M shares. That is +2.6% by share count (+728.31K shares) versus the previous quarter, while reported value moved +35.7%. Ownership is concentrated: the five largest holders account for 37.1% of reported value and the top ten for 59.5%.
Compared with the prior quarter, 46 opened new positions, 43 added to existing stakes, 12 trimmed, 6 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
Major shareholders of LB PHARMACEUTICALS INC (LBRX) include Deep Track Capital, LP, BlackRock Inc, RA CAPITAL MANAGEMENT, L.P., ranked by reported 13F value among the 171 institutional holders on this page.
LBRX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 94 | 13.80M | $525.23M | +11.1% |
| Q2 2026 | 121 | 30.51M | $989.67M | +2.6% |
| Q1 2026 | 81 | 28.60M | $701.68M | +5.7% |
| Q4 2025 | 69 | 24.98M | $555.77M | +8.2% |
| Q3 2025 | 55 | 21.08M | $328.44M | — |
Over the 5 quarters shown, institutional share counts decreased 35% in aggregate (Q3 2025 → Q3 2026); the largest single-quarter swing was Q4 2025 (+8.2%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 2.35M | $90.07M | 0.00% | Reduce | |
| 1.40M | $53.86M | 8.56% | Add | |
| 1.44M | $53.84M | 0.01% | Reduce | |
| 1.10M | $42.21M | 0.00% | Add | |
| 1.07M | $41.23M | 1.89% | Add | |
| 1.10M | $39.54M | 0.00% | Add | |
| 800.00K | $30.70M | 3.49% | Hold | |
| 705.40K | $27.07M | 0.00% | Add | |
| 630.66K | $24.20M | 16.35% | Hold | |
| 624.47K | $23.97M | 0.00% | Add | |
| 284.23K | $10.95M | 0.05% | New | |
| 221.15K | $8.49M | 0.00% | Add | |
| 173.80K | $6.67M | 1.75% | Reduce | |
| 170.06K | $6.53M | 0.00% | Add | |
| 167.08K | $6.41M | 0.01% | Add | |
| 154.62K | $5.93M | 0.00% | Add | |
| 116.43K | $4.47M | 0.00% | Add | |
| 82.34K | $3.16M | 0.38% | Hold | |
| 70.39K | $2.70M | 0.00% | Add | |
| 69.55K | $2.67M | 1.16% | Add | |
| 65.18K | $2.50M | 0.02% | Add | |
| 65.03K | $2.50M | 0.00% | Add | |
| 57.98K | $2.23M | 0.00% | Add | |
| 47.19K | $1.81M | 0.00% | Add | |
| 42.73K | $1.64M | 0.01% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.35M | $108.82M | 1.62% | Hold | |
| 2.73M | $88.74M | 0.00% | Add | |
| 2.21M | $71.68M | 0.62% | Hold | |
| 1.52M | $49.43M | 7.85% | Add | |
| 1.50M | $48.87M | 0.01% | Add | |
| 1.50M | $48.68M | 2.90% | Hold | |
| 1.45M | $46.97M | 1.13% | Reduce | |
| 1.44M | $46.67M | 2.73% | Hold | |
| 1.38M | $44.66M | 8.76% | Hold | |
| 1.05M | $34.17M | 1.37% | Hold | |
| 971.16K | $31.52M | 0.00% | Add | |
| 921.47K | $29.91M | 0.10% | Hold | |
| 863.95K | $28.04M | 0.07% | Hold | |
| 800.00K | $25.96M | 2.37% | Hold | |
| 630.66K | $20.47M | 15.57% | Hold | |
| 612.79K | $19.89M | 0.00% | New | |
| 612.79K | $19.89M | 0.00% | Add | |
| 585.00K | $18.99M | 0.82% | Reduce | |
| 576.46K | $18.71M | 0.01% | Add | |
| 540.90K | $17.55M | 0.01% | Hold | |
| 317.22K | $10.30M | 2.16% | Add | |
| 275.68K | $8.95M | 0.18% | New | |
| 259.22K | $8.41M | 0.00% | Add | |
| 259.22K | $8.41M | 0.01% | Add | |
| 227.49K | $7.38M | 0.00% | Add |
Q1 2026 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.35M | $82.68M | 1.35% | Hold | |
| 2.47M | $60.93M | 0.00% | Add | |
| 2.21M | $54.46M | 0.58% | Hold | |
| 1.84M | $45.28M | 1.29% | Add | |
| 1.50M | $36.99M | 2.14% | Hold | |
| 1.44M | $34.63M | 2.67% | New | |
| 1.38M | $33.64M | 8.09% | Add | |
| 1.43M | $33.19M | 0.00% | Reduce | |
| 1.32M | $32.54M | 7.92% | Reduce | |
| 1.05M | $25.96M | 1.19% | Add | |
| 923.69K | $22.78M | 0.07% | Add | |
| 915.00K | $22.56M | 1.20% | Reduce | |
| 894.65K | $22.06M | 0.00% | New | |
| 863.95K | $21.28M | 0.06% | Add | |
| 800.00K | $19.73M | 1.64% | Hold | |
| 630.66K | $15.55M | 12.82% | Add | |
| 538.22K | $13.27M | 0.01% | Reduce | |
| 518.23K | $12.78M | 0.00% | Add | |
| 504.37K | $12.44M | 0.00% | Add | |
| 416.91K | $10.28M | 0.02% | Add | |
| 363.80K | $8.97M | 0.00% | Add | |
| 300.00K | $7.40M | 1.70% | New | |
| 222.51K | $5.49M | 0.00% | Hold | |
| 200.00K | $4.93M | 0.03% | Hold | |
| 186.09K | $4.59M | 0.00% | Add |
Q4 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.35M | $74.63M | 1.33% | Hold | |
| 2.24M | $49.84M | 0.00% | Add | |
| 2.21M | $49.16M | 0.50% | Add | |
| 1.75M | $38.84M | 1.29% | Hold | |
| 1.61M | $35.87M | 0.01% | Add | |
| 1.50M | $33.39M | 2.22% | Hold | |
| 1.40M | $31.07M | 7.68% | New | |
| 1.20M | $26.71M | 1.93% | Add | |
| 1.11M | $24.77M | 0.00% | New | |
| 1.01M | $22.38M | 7.40% | New | |
| 896.81K | $19.96M | 0.07% | Reduce | |
| 821.85K | $18.29M | 0.01% | Add | |
| 800.00K | $17.81M | 1.15% | Hold | |
| 675.00K | $15.03M | 0.04% | Hold | |
| 675.00K | $15.03M | 0.75% | Hold | |
| 441.45K | $9.83M | 0.00% | Add | |
| 407.67K | $9.07M | 0.01% | Reduce | |
| 303.12K | $6.75M | 0.00% | Reduce | |
| 300.00K | $6.68M | 5.98% | Hold | |
| 250.03K | $5.57M | 0.00% | New | |
| 221.87K | $4.94M | 0.00% | Reduce | |
| 200.00K | $4.45M | 0.03% | Hold | |
| 193.54K | $4.31M | 0.00% | Add | |
| 177.62K | $3.95M | 0.00% | New | |
| 177.62K | $3.95M | 0.00% | New |
Q3 2025 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 3.35M | $52.94M | 1.48% | New | |
| 1.78M | $28.06M | 0.35% | New | |
| 1.75M | $27.55M | 1.35% | New | |
| 1.50M | $23.68M | 1.16% | New | |
| 1.13M | $17.84M | 1.88% | New | |
| 1.03M | $16.30M | 0.00% | New | |
| 975.00K | $15.40M | 0.00% | New | |
| 968.27K | $15.29M | 0.05% | New | |
| 800.00K | $12.63M | 1.02% | New | |
| 739.04K | $11.67M | 0.01% | New | |
| 675.00K | $10.66M | 0.03% | New | |
| 675.00K | $10.66M | 0.42% | New | |
| 539.37K | $8.52M | 0.01% | New | |
| 538.17K | $8.50M | 0.01% | New | |
| 538.17K | $8.50M | 0.00% | New | |
| 400.00K | $6.32M | 0.32% | New | |
| 369.10K | $5.83M | 0.00% | New | |
| 344.66K | $5.44M | 0.00% | New | |
| 344.66K | $5.44M | 0.00% | New | |
| 343.52K | $5.42M | 0.00% | New | |
| 300.00K | $4.74M | 7.95% | New | |
| 282.64K | $4.46M | 0.00% | New | |
| 255.53K | $4.03M | 0.01% | New | |
| 200.00K | $3.16M | 0.01% | New | |
| 200.00K | $3.16M | 0.02% | New |
New Positions (Q2 2026)
- GEODE CAPITAL MANAGEMENT, LLC 612.79K sh · $19.89M
- BOOTHBAY FUND MANAGEMENT, LLC 275.68K sh · $8.95M
- Sixth Street Partners Management Company, L.P. 195.49K sh · $6.34M
- RAYMOND JAMES FINANCIAL INC 91.66K sh · $2.97M
- Longbow Finance SA 82.34K sh · $2.67M
- NEXTBio Capital Management LP 68.25K sh · $2.22M
- ALERUS FINANCIAL NA 54.89K sh · $1.78M
- XTX Topco Ltd 47.01K sh · $1.53M
- Y-Intercept (Hong Kong) Ltd 39.41K sh · $1.28M
- GREAT LAKES ADVISORS, LLC 30.41K sh · $986.96K
- Swiss National Bank 30.20K sh · $980.14K
- ALPS ADVISORS INC 29.10K sh · $944.50K
Fully Exited (vs previous quarter)
- STATE STREET CORP sold 504.37K sh · $12.44M
- Janus Henderson Group sold 65.43K sh · $1.61M
- Opaleye Management Inc. sold 14.51K sh · $357.72K
- Soleus Capital Management, L.P. sold 10.00K sh · $246.60K
- STRS OHIO sold 5.10K sh · $125.77K
- CWM, LLC sold 29 sh · $715
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 |
|---|---|---|---|---|---|
| BlackRock Inc | 2.35M | 2.73M | 2.47M | 2.24M | 975.00K |
| Spruce Street Capital LP | 1.40M | 1.38M | 1.38M | 1.01M | — |
| JPMorgan Chase & Co | 1.44M | 1.50M | 1.43M | 1.61M | 1.03M |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.10M | 971.16K | 894.65K | — | — |
| Nantahala Capital Management, LLC | 1.07M | 1.05M | 1.05M | 675.00K | 675.00K |
| Fidelity Management & Research (FMR) | 1.10M | 188.91K | 222.51K | 221.87K | 369.10K |
| Vivo Capital, LLC | 800.00K | 800.00K | 800.00K | 800.00K | 800.00K |
| STATE STREET CORP | 705.40K | — | 504.37K | 250.03K | — |
| Nan Fung Group Holdings Ltd | 630.66K | 630.66K | 630.66K | 300.00K | 300.00K |
| Geode Capital Management | 624.47K | 612.79K | 518.23K | 441.45K | 13.59K |
| Candriam S.C.A. | 284.23K | — | — | — | — |
| UBS Group AG | 221.15K | 85.95K | 137.93K | 50.71K | 1.05K |
| HighVista Strategies LLC | 173.80K | 211.51K | 173.59K | 140.11K | — |
| VANGUARD FIDUCIARY TRUST CO | 170.06K | 162.80K | 157.43K | — | — |
| BNP PARIBAS FINANCIAL MARKETS | 167.08K | 86.37K | 4.05K | 4.01K | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 154.62K | 152.16K | 112.50K | — | — |
| Morgan Stanley | 116.43K | 51.21K | 47.28K | 24.64K | 9.61K |
| Longbow Finance SA | 82.34K | 82.34K | — | 82.34K | — |
| Nuveen, LLC | 70.39K | 52.14K | 22.97K | 22.97K | — |
| NEXTBio Capital Management LP | 69.55K | 68.25K | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold LBRX?
As of 2026-Q2, 121 institutional funds reported holding LBRX (LB PHARMACEUTICALS INC) in SEC 13F filings, with a combined reported value of $989.67M.
How many shares of LBRX do institutions own?
13F filers reported 30.51M shares of LBRX, worth $989.67M in aggregate at the end of 2026-Q2.
Is institutional ownership of LBRX rising or falling?
Share counts moved +2.6% versus the prior quarter — accumulation.
Who are the top institutional holders of LBRX?
The largest 13F holders are Deep Track Capital, LP, BlackRock Inc, RA CAPITAL MANAGEMENT, L.P., Spruce Street Capital LP, JPMorgan Chase & Co; the top 25 are ranked at the top of this page.
Who are the major shareholders of LB PHARMACEUTICALS INC?
The major shareholders of LB PHARMACEUTICALS INC (LBRX) by reported 13F value are Deep Track Capital, LP, BlackRock Inc, RA CAPITAL MANAGEMENT, L.P., Spruce Street Capital LP, JPMorgan Chase & Co, among 171 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.